surmount-1 tirzepatide 15 mg weight loss percent (NEJM 2022) tested — a dual GIP/GLP-1 receptor agonist — in 2,539 adults with obesity and achieved up to 20.9% mean at the highest dose. 57% of participants Tirzepatide Yields Top Weight Loss

At Cymbiotika, we are committed to staying informed about the latest research and ensuring that our product formulations are grounded in scientific evidence

We provide a telehealth-first experience that connects you with licensed healthcare providers who specialize in metabolic health

Glutathione S-transferase Mu 2-transduced mesenchymal stem cells ameliorated anti-glomerular basement membrane antibody-induced glomerulonephritis by inhibiting oxidation and inflammation

This uncertainty may reflect limitations in statistical power, particularly for MR-Egger, which requires stronger assumptions and larger sample sizes to detect causal effects

Green tea: Green tea contains catechins and other polyphenols that may help slow the breakdown of GLP-1 in the bloodstream, extending its effects after meals